An international collaborative study to establish the WHO 1st international standards for C1-inhibitor, plasma and concentrate

J Thromb Haemost. 2011 Oct;9(10):2097-9. doi: 10.1111/j.1538-7836.2011.04455.x.

Authors

C Thelwel¹, P Rigsby, C Longstaff; ISTH-SSC Subcommittee on Factor XI and Contact System

Collaborators

ISTH-SSC Subcommittee on Factor XI and Contact System:
S Breitner-Ruddock, N Zander, C Michalski, S Linstead, H Blessing, B Kerbl, D Wouters, E Nieuwenhuys, K Abbink-Wiersum, P Gartner, L A Varga, R Zadro, M Cicardi, E Langer, E Karnaukhova, M Lopez-Trascasa, P Nozal, C Drouet, S Regenass, E W Nielson, E Marzsal, M Wirz, F Luciani, C Thelwell, P Whitfield, W Egner, K Dengler, K Masselou, T Plant, W Korte, P Roux-Lombard, E Aygoeren, W Kreuz

Affiliation

¹ Biotherapeutics Group, Haemostasis Section, National Institute for Biological Standards and Control, South Mimms, UK. [email protected]

PMID: 22053337
DOI: 10.1111/j.1538-7836.2011.04455.x

No abstract available

MeSH terms

Complement C1 Inhibitor Protein / metabolism
Complement C1 Inhibitor Protein / standards*
Humans
International Cooperation
Plasma
World Health Organization

Substances

Complement C1 Inhibitor Protein